Safety and Feasibility of Intravenous Paracetamol for Patent Ductus Arteriosus in Indomethacin-/Ibuprofen-Resistant or -Contraindicated Preterm Infants: A Case Series

• Main Authors: Ayumi Oshima (Author), Shun Matsumura (Author), Ayaka Iwatani (Author), Machiko Morita (Author), Sumie Fujinuma (Author), Yukiko Motojima (Author), Kosuke Tanaka (Author), Satoshi Masutani (Author), Kazuhiko Kabe (Author), Keiko Ueda (Author), Fumihiko Namba (Author)
• Format: Book
• Published: Thieme Medical Publishers, Inc., 2020-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background Although indomethacin and ibuprofen are the standard treatments for hemodynamically significant patent ductus arteriosus (hsPDA), they are associated with renal impairment and gastrointestinal complications. Paracetamol for hsPDA closure does not provoke a peripheral vasoconstrictive effe...